论文部分内容阅读
本文采用CAl9-19、CEA、AFP三种肿瘤相关抗 原对154例消化系统恶性肿瘤及84例良性疾病进 行检测,探讨其临床应用价值,现将结果报告如下。 对象和方法 一、对象:(一)正常对照组:40例(男20,女20),年龄23～63岁,中位值45岁,均经我院体检的健康正常人。(二)消化系良性病组:系我院门诊及住院患者,经B超、内窥镜、CT、PTC/ERCP及肿瘤标志物检测并经随访一年以上而确诊者84例(男52,女32),年龄19～65岁,中位值50.4岁。(三)消化系恶性肿瘤组:154例(男89,女65)均
In this article, we used the three tumor-associated antigens (CAl9-19, CEA, and AFP) to detect 154 cases of malignant tumors of the digestive system and 84 cases of benign diseases to discuss their clinical application value. The results are reported below. Subjects and methods 1. Subjects: (1) Normal control group: 40 normal cases (male 20, female 20), aged 23-63 years, median value 45 years old, all of whom were normal healthy subjects examined in our hospital. (B) Digestive system benign disease group: Department of outpatients and inpatients in our hospital, after B-ultrasound, endoscopy, CT, PTC/ERCP and tumor markers detected and followed up for more than one year, 84 patients were diagnosed (male 52, Female 32), aged 19 to 65 years, median 50.4 years old. (III) Digestive System Malignancy: 154 cases (male 89, female 65)